Papageorgiou, S. G., Kotsianidis, I., Bouchla, A., Symeonidis, A., Galanopoulos, A., Viniou, N., . . . Pappa, V. (2020). Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: A retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes. Ther Adv Hematol.
Stile di citazione ChicagoPapageorgiou, Sotirios G., et al. "Serum Ferritin and ECOG Performance Status Predict the Response and Improve the Prognostic Value of IPSS or IPSS-R in Patients With High-risk Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia Treated With 5-azacytidine: A Retrospective Analysis of the Hellenic National Registry of Myelodysplastic and Hypoplastic Syndromes." Ther Adv Hematol 2020.
Citazione MLAPapageorgiou, Sotirios G., et al. "Serum Ferritin and ECOG Performance Status Predict the Response and Improve the Prognostic Value of IPSS or IPSS-R in Patients With High-risk Myelodysplastic Syndromes and Oligoblastic Acute Myeloid Leukemia Treated With 5-azacytidine: A Retrospective Analysis of the Hellenic National Registry of Myelodysplastic and Hypoplastic Syndromes." Ther Adv Hematol 2020.